Skip to main content

Table 1 Clinical characteristics

From: The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn’s disease

 

CD

UC

BD

Control

P value

Number of patients

39

51

17

16

 

Gender

     

 Male

20

27

9

14

0.070

 Female

19

24

8

2

Mean age (±SD), yr

32.4 ± 14.5

45.2 ± 22.8

47.5 ± 17.6

32.4 ± 3.8

0.014

BMI (±SD), kg/m2

19.0 ± 3.6

21.6 ± 3.7

20.4 ± 3.8

 

0.006

CDAI

     

  ≥ 150

12

    

  < 150

27

    

CAI

     

  ≥ 6

 

29

   

  < 6

 

22

   

Disease location

     

 CD

     

  Ileal type

9

    

  Ileocolonic type

25

    

  Colonic type

4

    

  Unknown

1

    

 UC

     

  Pancolitis

 

41

   

  Left side colon

 

4

   

  Rectum

 

5

   

  Unknown

 

1

   

Current treatment

     

  5-ASA

25

43

13

  

  Steroid

2

18

6

  

  Azathioprine

0

5

0

  

  Infliximab

5

0

0

  

  Adalimumab

1

0

0

  

  GMA/LCAP

1

6

1

  

AIM (μg/ml)

     

 Average (±SD)

3.3 ± 2.1

1.9 ± 1.4

2.3 ± 1.4

2.1 ± 0.6

<0.001

WBC (±SD), x102/μl

6.7 ± 2.6

8.4 ± 3.9

7.3 ± 2.8

0.055

CRP (±SD), mg/dl

2.5 ± 3.5

3.6 ± 5.8

2.7 ± 4.0

0.929

IgM (±SD), mg/dl

141.5 ± 124.3

118.0 ± 77.9

118.0 ± 64.9

0.275

  1. Abbreviations: GMA/LCAP granulocyte and monocyte adsorptive apheresis / leukocytapheresis, WBC White blood cell, CRP C-reactive protein, IgM Immunoglobulin M